Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             36 results found
no title author magazine year volume issue page(s) type
1 A low-cost solar-powered blood-pressure device Sliwa, Karen
2011
378 9792 p. 647-648
2 p.
article
2 Antithrombin alternatives in STEMI Stone, Gregg W
2011
378 9792 p. 643-645
3 p.
article
3 Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study Blaha, Michael J
2011
378 9792 p. 684-692
9 p.
article
4 Cardiac myosin activation: will theory and practice coincide? Dickstein, Kenneth
2011
378 9792 p. 639-641
3 p.
article
5 Coagulation: cascade! Olah, Zsolt
2011
378 9792 p. 740-
1 p.
article
6 Doctors striking in Israel The Lancet,
2011
378 9792 p. 638-
1 p.
article
7 Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study Teerlink, John R
2011
378 9792 p. 667-675
9 p.
article
8 Give me shelter Boyce, Niall
2011
378 9792 p. 656-
1 p.
article
9 Implantable cardioverter defibrillators and cardiac resynchronisation therapy Holzmeister, Johannes
2011
378 9792 p. 722-730
9 p.
article
10 Injectable extended-release naltrexone for opioid dependence Throckmorton, Douglas C
2011
378 9792 p. 665-666
2 p.
article
11 Injectable extended-release naltrexone for opioid dependence Woody, George E
2011
378 9792 p. 664-665
2 p.
article
12 Injectable extended-release naltrexone for opioid dependence Krupitsky, Evgeny
2011
378 9792 p. 665-
1 p.
article
13 Injectable extended-release naltrexone for opioid dependence – Authors' reply Wolfe, Daniel
2011
378 9792 p. 666-
1 p.
article
14 In search of new therapeutic targets and strategies for heart failure: recent advances in basic science Shah, Ajay M
2011
378 9792 p. 704-712
9 p.
article
15 Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial Montalescot, Gilles
2011
378 9792 p. 693-703
11 p.
article
16 John Teerlink: Renaissance man and leader in heart failure research Holmes, David
2011
378 9792 p. 657-
1 p.
article
17 Kumariah Balasubramaniam Pincock, Stephen
2011
378 9792 p. 660-
1 p.
article
18 Laos builds specialty training system through partnerships Nightingale, Katherine
2011
378 9792 p. 653-654
2 p.
article
19 Medical therapy for chronic heart failure Krum, Henry
2011
378 9792 p. 713-721
9 p.
article
20 New antithrombotic drugs and European approval processes Marijon, Eloi
2011
378 9792 p. 662-663
2 p.
article
21 Offline: The great European betrayal Horton, Richard
2011
378 9792 p. 650-
1 p.
article
22 On the horizon in heart failure The Lancet,
2011
378 9792 p. 637-
1 p.
article
23 Pakistan prepares to abolish Ministry of Health Nishtar, Sania
2011
378 9792 p. 648-649
2 p.
article
24 Predictive ability of coronary artery calcium and CRP Schmermund, Axel
2011
378 9792 p. 641-643
3 p.
article
25 Promise of extended-release naltrexone is a red herring Bart, Gavin
2011
378 9792 p. 663-
1 p.
article
26 Promise of extended-release naltrexone is a red herring – Authors' reply Krupitsky, Evgeny
2011
378 9792 p. 663-664
2 p.
article
27 Radial versus femoral access in acute coronary syndromes Pristipino, Christian
2011
378 9792 p. 661-
1 p.
article
28 Radial versus femoral access in acute coronary syndromes Chong, Aun-Yeong
2011
378 9792 p. 661-
1 p.
article
29 Radial versus femoral access in acute coronary syndromes – Authors' reply Jolly, Sanjit S
2011
378 9792 p. 661-662
2 p.
article
30 South Africa should step up oversight of maternal care The Lancet,
2011
378 9792 p. 638-
1 p.
article
31 Telemedicine and remote management of patients with heart failure Anker, Stefan D
2011
378 9792 p. 731-739
9 p.
article
32 The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial Cleland, John GF
2011
378 9792 p. 676-683
8 p.
article
33 The past is never dead Bynum, Bill
2011
378 9792 p. 655-656
2 p.
article
34 Unexpected life lessons from cardiac anatomy and physiology Sanghavi, Darshak M
2011
378 9792 p. 658-659
2 p.
article
35 US physicians urge end to unnecessary stent operations Devi, Sharmila
2011
378 9792 p. 651-652
2 p.
article
36 Why not screen for subclinical atherosclerosis? Sillesen, Henrik
2011
378 9792 p. 645-646
2 p.
article
                             36 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands